Glory Health Industry (HKSE:02329) EBIT: HK$-948 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Glory Health Industry EBIT?

Glory Health Industry HKSE:02329 +1.12% EBIT is HK$-948 Mil as of Dec. 2025. The stock has 5 warning signs investors should review.

Glory Health Industry's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was HK$-1,060 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-948 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Glory Health Industry's annualized ROC % for the quarter that ended in Dec. 2025 was -2.27%. Glory Health Industry's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -38.68%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Glory Health Industry's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -3.05%.


Glory Health Industry  (HKSE:02329) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Glory Health Industry's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=-1400.5854571133 * ( 1 - 6.649% )/( (58297.053541274 + 56765.123474023)/ 2 )
=-1307.4605300699/57531.088507649
=-2.27 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=62258.033940409 - 3742.9562486917 - ( 218.0241504431 - max(0, 34188.780559626 - 35063.289512246+218.0241504431))
=58297.053541274

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=60353.557390797 - 3500.9393639948 - ( 153.84334487668 - max(0, 32116.394060159 - 32203.888612938+153.84334487668))
=56765.123474023

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Glory Health Industry's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-2120.4886810726/( ( (2847.072465285 + max(2194.2927360268, 0)) + (2366.6622717744 + max(3557.1970003508, 0)) )/ 2 )
=-2120.4886810726/( ( 5041.3652013118 + 5923.8592721252 )/ 2 )
=-2120.4886810726/5482.6122367185
=-38.68 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=( + 23812.708513014 + ) - (3742.9562486917 + 6179.1446723885 + 11696.314855907)
=2194.2927360268

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=( + 23121.504276382 + ) - (3500.9393639948 + 5805.1155509684 + 10258.252361068)
=3557.1970003508

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Glory Health Industry's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=-948.276/31096.500
=-3.05 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Glory Health Industry EBIT Related Terms


Glory Health Industry EBIT Historical Data

* Premium members only.

The historical data trend for Glory Health Industry's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Glory Health Industry EBIT Chart

Glory Health Industry Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,304.47 -473.27 -23.52 -330.34 -1,212.33

Glory Health Industry Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -88.27 -242.15 -160.45 -1,060.24 50.66

Glory Health Industry EBIT Competitor Comparison

For the Real Estate - Development subindustry, Glory Health Industry's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Glory Health Industry EV-to-EBIT vs Real Estate Industry

For the Real Estate industry and Real Estate sector, Glory Health Industry's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Glory Health Industry's EV-to-EBIT falls into.



Glory Health Industry EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-948 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of HK$-948 Mil mean?
Glory Health Industry (HKSE:02329) has a EBIT of HK$-948 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Glory Health Industry.
Is Glory Health Industry's EBIT too high?
Glory Health Industry's current EBIT is HK$-948 Mil.
How does Glory Health Industry's EBIT compare to competitors?
Glory Health Industry's EBIT of HK$-948 Mil can be compared against companies in the Real Estate industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Real Estate company?
A good EBIT depends on the Real Estate industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Glory Health Industry. Glory Health Industry's current EBIT is HK$-948 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Glory Health Industry stock overvalued right now?
Based on GuruFocus' analysis, Glory Health Industry (HKSE:02329) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.04, compared to a current price of HK$0.09 — trading 125% above its estimated fair value. The current EBIT is HK$-948 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Glory Health Industry (HKSE:02329), the current EBIT is HK$-948 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Glory Health Industry Business Description

Address Chongwenmenwai Street, Building 1, East Block, Hademen Plaza, No. 8 Courtyard, Dongcheng District, Beijing, CHN, 100062
Glory Health Industry Ltd is an investment holding company. The company's operating segments are Property development that develops and sells commercial and residential properties; primary land construction and development services that derive revenue from primary land development, including services for resettlement, construction of land infrastructure, and ancillary public facilities on land owned by the local governments; Property investment that derives rental income from investment properties developed by the group; and Property management that derive income from property management and related services. The majority of the revenue is derived from the Property development segment. All the company's revenue is derived from the PRC.